Abattis Bioceuticals Corp.Β (CSE:ATT) (OTC:ATTBF) (FRA:115)
CSE Ticker Symbol:
OTC Ticker Symbol:
Frankfurt Ticker Symbol:


Abattis Bioceuticals Corp.Β (CSE:ATT) (OTC:ATTBF) (FRA:115) is a leading diversified cannabis company, with interests in operations engaged in growing, extraction, testing, propagation and retail distribution. Over the past few years, Abattis has made key acquisitions to leverage synergies and vertically integrate its business. Through Abattis’s ownership interest in Northern Vine Labs, Abattis has access to a laboratory facility holding a Health Canada dealer’s license and, through its wholly owned subsidiary Gabriola Green Farms, it has applied for a Health Canada license to produce and sell Cannabis flower and oils. Abattis also operates a retail vaporizers business through its wholly owned subsidiary, Green Tree Therapeutics, which offers 10 unique branded SKUs online and across the country and owns a series of marketing, licensing and technology rights. Abattis has also partnered with a number of organizations, including the University of British Columbia Faculty of Land and Food Systems, with which it is developing delivery platforms with increased stability and bioavailability for cannabinoid rich THC-free hemp extracts.

ZIP Code:
V6C 3E8
Business Website Address:
Business Phone Number:
1 (604) 674-8232